ASO Author Reflections: Inflammatory Breast Cancer: Durable Breast Cancer-Specific Survival for HER2-Positive Patients with a Pathologic Complete Response to Neoadjuvant Therapy

Tina J. Hieken; Tanya L. Hoskin

doi:10.1245/s10434-022-12181-0

ASO Author Reflections: Inflammatory Breast Cancer: Durable Breast Cancer-Specific Survival for HER2-Positive Patients with a Pathologic Complete Response to Neoadjuvant Therapy

Gastroenterologic and General Surgery

Research output: Contribution to journal › Comment/debate › peer-review

Original language	English (US)
Pages (from-to)	597-598
Number of pages	2
Journal	Annals of surgical oncology
Volume	29
DOIs	https://doi.org/10.1245/s10434-022-12181-0
State	Published - Dec 2022

ASJC Scopus subject areas

Surgery
Oncology

Access to Document

10.1245/s10434-022-12181-0

Cite this

@article{a042ac40961d4a2eaf8fa060400174e3,

title = "ASO Author Reflections: Inflammatory Breast Cancer: Durable Breast Cancer-Specific Survival for HER2-Positive Patients with a Pathologic Complete Response to Neoadjuvant Therapy",

author = "Hieken, {Tina J.} and Hoskin, {Tanya L.}",

note = "Funding Information: Tina J. Hieken MD has unrelated research funding from SkylineDX BV and Genentech. Tanya L. Hoskin has no disclosures to declare. ",

year = "2022",

month = dec,

doi = "10.1245/s10434-022-12181-0",

language = "English (US)",

volume = "29",

pages = "597--598",

journal = "Annals of surgical oncology",

issn = "1068-9265",

publisher = "Springer New York",

}

TY - JOUR

T1 - ASO Author Reflections

T2 - Inflammatory Breast Cancer: Durable Breast Cancer-Specific Survival for HER2-Positive Patients with a Pathologic Complete Response to Neoadjuvant Therapy

AU - Hieken, Tina J.

AU - Hoskin, Tanya L.

N1 - Funding Information: Tina J. Hieken MD has unrelated research funding from SkylineDX BV and Genentech. Tanya L. Hoskin has no disclosures to declare.

PY - 2022/12

Y1 - 2022/12

UR - http://www.scopus.com/inward/record.url?scp=85133584304&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85133584304&partnerID=8YFLogxK

U2 - 10.1245/s10434-022-12181-0

DO - 10.1245/s10434-022-12181-0

M3 - Comment/debate

C2 - 35798892

AN - SCOPUS:85133584304

SN - 1068-9265

VL - 29

SP - 597

EP - 598

JO - Annals of surgical oncology

JF - Annals of surgical oncology

ER -

ASO Author Reflections: Inflammatory Breast Cancer: Durable Breast Cancer-Specific Survival for HER2-Positive Patients with a Pathologic Complete Response to Neoadjuvant Therapy

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this